Changes

Jump to navigation Jump to search
no edit summary
The [[Prize System for Inventions|Prize Fund]] for HIV/AIDS Act is a patent reform act proposed in a previous congressional session.
See: https://www.congress.gov/bill/112th-congress/senate-bill/1138
==Summary==
The act nullifies patents on manufacturing processes of drugs, so that no company may hold the patent on the manufacturing process of a drug. However, a company becomes eligible for prize funds by holding a patent on the manufacturing process they use to create a drug. [Bill language: ''...in the case of a manufacturing process for a qualifying treatment for HIV/AIDS, the holder of the patent with respect to such process...'']. No new firms may be eligible for prize funds if they use a manufacturing process they did not hold a patent for.
 
[[Category: Public]]
[[Public Classification::Legislation| ]]

Navigation menu